>
Innovation Pharmaceuticals Inc logo

IPIX - Innovation Pharmaceuticals Inc Share Price

$0.27 -0.0  -1.8%

Last Trade - 13/04/21

Sector
Healthcare
Size
Small Cap
Market Cap £71.4m
Enterprise Value £67.9m
Revenue £16.7k
Position in Universe 5190th / 6841
Bullish
Bearish
Unlock IPIX Revenue
Momentum
Relative Strength (%)
1m -16.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -57.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.42
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020,Innovation Pharmaceuticals Inc revenues decreased from$400K to $0K. Net loss increased 76% to $7.3M. Revenuesreflect a decrease in demand for the Company's products andservices due to unfavorable market conditions. Higher netloss reflects Interest Exp-Net of Capitalized Intereincrease from $40K to $2.7M (expense), Research &Development Expense increase from $676K to $3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IPIX Revenue Unlock IPIX Revenue

Net Income

IPIX Net Income Unlock IPIX Revenue

Normalised EPS

IPIX Normalised EPS Unlock IPIX Revenue

PE Ratio Range

IPIX PE Ratio Range Unlock IPIX Revenue

Dividend Yield Range

IPIX Dividend Yield Range Unlock IPIX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
IPIX EPS Forecasts Unlock IPIX Revenue
Profile Summary

Innovation Pharmaceuticals Inc., formerly Cellceutix Corporation, is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies with oncology, dermatology and antimicrobial applications. The Company owns the rights to various drug compounds, including Kevetrin (thioureidobutyronitrile), which is its anti-cancer compound; Prurisol (KM-133), which is in development for psoriasis, and Brilacidin, which is its drug in a class of compounds known as defensin-mimetics. The Company's clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Prurisol for the treatment of psoriasis, and Brilacidin for treatments of skin infections, prevention of oral mucositis complicating chemoradiation treatment for cancer, and ulcerative proctitis. The Company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics and inflammatory disease.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated August 1, 2005
Public Since April 2, 2007
No. of Shareholders: 68
No. of Employees: 4
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 357,110,096
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
IPIX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IPIX
Upcoming Events for IPIX
Frequently Asked Questions for Innovation Pharmaceuticals Inc
What is the Innovation Pharmaceuticals Inc share price?

As of 13/04/21, shares in Innovation Pharmaceuticals Inc are trading at $0.27, giving the company a market capitalisation of £71.4m. This share price information is delayed by 15 minutes.

How has the Innovation Pharmaceuticals Inc share price performed this year?

Shares in Innovation Pharmaceuticals Inc are currently trading at $0.27 and the price has moved by 0.155k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Innovation Pharmaceuticals Inc price has moved by 68.67% over the past year.

What are the analyst and broker recommendations for Innovation Pharmaceuticals Inc?

There are no analysts currently covering Innovation Pharmaceuticals Inc.

When will Innovation Pharmaceuticals Inc next release its financial results?

Innovation Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Innovation Pharmaceuticals Inc dividend yield?

Innovation Pharmaceuticals Inc does not currently pay a dividend.

Does Innovation Pharmaceuticals Inc pay a dividend?

Innovation Pharmaceuticals Inc does not currently pay a dividend.

When does Innovation Pharmaceuticals Inc next pay dividends?

Innovation Pharmaceuticals Inc does not currently pay a dividend.

How do I buy Innovation Pharmaceuticals Inc shares?

To buy shares in Innovation Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Innovation Pharmaceuticals Inc?

Shares in Innovation Pharmaceuticals Inc are currently trading at $0.27, giving the company a market capitalisation of £71.4m.

Where are Innovation Pharmaceuticals Inc shares listed? Where are Innovation Pharmaceuticals Inc shares listed?

Here are the trading details for Innovation Pharmaceuticals Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: IPIX
What kind of share is Innovation Pharmaceuticals Inc?

Based on an overall assessment of its quality, value and momentum, Innovation Pharmaceuticals Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Innovation Pharmaceuticals Inc share price forecast 2021?

We were not able to load any forecast data for Innovation Pharmaceuticals Inc.

How can I tell whether the Innovation Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovation Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 6.07%. At the current price of $0.27, shares in Innovation Pharmaceuticals Inc are trading at 10.06% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Innovation Pharmaceuticals Inc PE Ratio?

We were not able to find PE ratio data for Innovation Pharmaceuticals Inc.

Who are the key directors of Innovation Pharmaceuticals Inc?

Innovation Pharmaceuticals Inc's management team is headed by:

Leo Ehrlich - CHM
Barry Schechter - IND
Zorik Spektor - IND
Jane Harness - SVP
Who are the major shareholders of Innovation Pharmaceuticals Inc?

Here are the top five shareholders of Innovation Pharmaceuticals Inc based on the size of their shareholding:

Kips Bay Select LP Corporation
Percentage owned: 5.02% (21.0m shares)
Leviston Resources LLC Corporation
Percentage owned: 3.82% (16.0m shares)
Ehrlich (Leo) Individual Investor
Percentage owned: 2.53% (10.6m shares)
Bertolino Arthur Peter Individual Investor
Percentage owned: 0.21% (881k shares)
Schechter (Barry Alan M.D.) Individual Investor
Percentage owned: 0.18% (750k shares)
Similar to IPIX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.